Tacrine
Back to searchMolecule Structure
Scientific Name
Tacrine
Description of the Drug
Tacrine is an anticholinesterase drug used for the management of Alzheimer’s disease symptoms.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00382
http://www.drugbank.ca/drugs/DB00382
Brand Name(s)
Not Available
Company Owner(s)
Shionogi Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cholinesterases; ACHE & BCHE | SELECTIVITY GROUP | INHIBITOR | CHEMBL2095233 |
Clinical Trial(s)
Unichem Links
Atlas | tacrine | |||
SureChEMBL | SCHEMBL2828 | |||
PharmGKB | PA451576 | |||
Human Metabolome Database | HMDB0014526 | |||
DrugBank | DB00382 | |||
PubChem: Thomson Pharma | 15120928 | |||
PubChem | 1935 | |||
Mcule | MCULE-3628803328 | |||
LINCS | LSM-5871 | |||
Nikkaji | J5.670G | |||
PDBe | THA | |||
BindingDB | 8961 | |||
EPA CompTox Dashboard | DTXSID1037272 | |||
DrugCentral | 2551 | |||
Brenda | 1456 | 220586 | 199427 | 29661 |
ChemicalBook | CB7699634 | |||
Guide to Pharmacology | 6687 | |||
rxnorm | TACRINE | TACRINE HYDROCHLORIDE | ||
KEGG Ligand | C01453 | |||
ChEBI | 45980 | |||
ZINC | ZINC000019014866 |